IDO1 and TDO are highly expressed in tumor cells, tumor stromal cells, dendritic cells, and macrophages in the tumor microenvironment, leading to the consumption of tryptophan and the accumulation of tryptophan-related metabolites (91, 92). The gene discussed is TDO2; the disease is neoplasm.